{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:29:28Z","timestamp":1782858568960,"version":"3.54.5"},"reference-count":42,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Osteoporosis is a prevalent metabolic bone disorder characterized by reduced bone mineral density (BMD) and increased fracture risk, particularly among older adults. While individual medications have been implicated in bone loss, the cumulative impact of polypharmacy on skeletal health remains underexplored. Methods: This cross-sectional study included 1155 geriatric inpatients undergoing routine bone mineral density assessment. Medication use, demographic characteristics, and clinical variables were extracted from electronic medical records. BMD at the lumbar spine (L1\u2013L4) and total hip was measured using dual-energy X-ray absorptiometry (DXA). Unadjusted analyses and multivariable linear regression models were used to examine associations between medication use, polypharmacy (defined as the use of \u22655 medications), and BMD, adjusting for age, sex, body mass index, and relevant clinical covariates. Results: The mean age of the study population was 85.0 \u00b1 7.1 years, and 80.1% were female. Polypharmacy was present in 64.5% of patients. In medication-specific analyses, thyroid hormone use was associated with lower lumbar spine BMD (p = 0.032), and concomitant use of diuretics and proton pump inhibitors was associated with lower hip BMD (p = 0.049). Steroid use showed a marginally non-significant correlation with reduced BMD (p = 0.057). Polypharmacy was associated with lower lumbar spine BMD (p = 0.022), whereas no significant association was observed with hip BMD. Increasing age was consistently associated with lower BMD across skeletal sites (p &lt; 0.001). Conclusions: In this geriatric inpatient cohort, polypharmacy and selected medication classes were associated with lower bone mineral density, particularly at the lumbar spine. Given the cross-sectional design, these findings reflect associations rather than causal relationships and may partly capture underlying multimorbidity and clinical complexity. Consideration of medication burden may be relevant when evaluating bone health in older adults. Polypharmacy is increasingly common in older adults and may contribute to bone fragility. In this cohort of 1155 geriatric inpatients, multiple medications and certain drug classes were associated with lower bone mineral density, particularly in the spine. These findings suggest that medication burden should be considered when evaluating osteoporosis risk in aging populations.<\/jats:p>","DOI":"10.3390\/jcm15031197","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T13:58:49Z","timestamp":1770127129000},"page":"1197","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of Polypharmacy and Bone Mineral Density: A Cross-Sectional Analysis of Geriatric Inpatients in Germany"],"prefix":"10.3390","volume":"15","author":[{"given":"Stylianos","family":"Kopanos","sequence":"first","affiliation":[{"name":"Academic Department of Endocrinology, Diabetes and Infectiology, Klinikum Bielefeld, Medical School, University Medical Centre East Westphalia-Lippe Bielefeld University, 33617 Bielefeld, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Nicole","family":"Scheel","sequence":"additional","affiliation":[{"name":"Academic Department of Endocrinology, Diabetes and Infectiology, Klinikum Bielefeld, Medical School, University Medical Centre East Westphalia-Lippe Bielefeld University, 33617 Bielefeld, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Eggert","sequence":"additional","affiliation":[{"name":"Academic Department of Endocrinology, Diabetes and Infectiology, Klinikum Bielefeld, Medical School, University Medical Centre East Westphalia-Lippe Bielefeld University, 33617 Bielefeld, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Thiem","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Medical School Ostwestfalen-Lippe (OWL), University of Bielefeld, 33647 Bielefeld, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5216-3851","authenticated-orcid":false,"given":"Joachim","family":"Feldkamp","sequence":"additional","affiliation":[{"name":"Academic Department of Endocrinology, Diabetes and Infectiology, Klinikum Bielefeld, Medical School, University Medical Centre East Westphalia-Lippe Bielefeld University, 33617 Bielefeld, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"ref_1","first-page":"193168","article-title":"Chronic Condition Clusters and Polypharmacy among Adults","volume":"2012","author":"Vyas","year":"2012","journal-title":"Int. J. Fam. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Rasool, M.F., Rehman, A.U., Khan, I., Latif, M., Ahmad, I., Shakeel, S., Sadiq, M., Hayat, K., Shah, S., and Ashraf, W. (2023). Assessment of risk factors associated with potential drug-drug interactions among patients suffering from chronic disorders. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0276277"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Masnoon, N., Shakib, S., Kalisch-Ellett, L., and Caughey, G.E. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatr., 17.","DOI":"10.1186\/s12877-017-0621-2"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40618-017-0753-4","article-title":"Thyroid diseases and bone health","volume":"41","author":"Williams","year":"2018","journal-title":"J. Endocrinol. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2174\/1874609809999160217101716","article-title":"Assessing Medication Problems in those \u2265 65 Using the STOPP and START Criteria","volume":"9","author":"Thomas","year":"2016","journal-title":"Curr. Aging Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11920-018-0960-5","article-title":"The Impact of Psychotropic Medications on Bone Health in Youth","volume":"20","author":"Rice","year":"2018","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40261-018-0716-3","article-title":"The Association between Polypharmacy and Hip Fracture in Osteoporotic Women: A Nested Case-Control Study in South Korea","volume":"39","author":"Park","year":"2019","journal-title":"Clin. Drug Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11657-021-00993-8","article-title":"Insufficient persistence to pharmacotherapy in Japanese patients with osteoporosis: An analysis of the National Database of Health Insurance Claims and Specific Health Checkups in Japan","volume":"16","author":"Nakatoh","year":"2021","journal-title":"Arch. Osteoporos."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.amjopharm.2012.02.003","article-title":"Polypharmacy with common diseases in hospitalized elderly patients","volume":"10","author":"Mizokami","year":"2012","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cger.2022.05.011","article-title":"Polypharmacy in Osteoporosis Treatment","volume":"38","author":"McConnell","year":"2022","journal-title":"Clin. Geriatr. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Aggarwal, P., Woolford, S.J., and Patel, H.P. (2020). Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice. Geriatrics, 5.","DOI":"10.20944\/preprints202009.0030.v1"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","article-title":"Polypharmacy cutoff and outcomes: Five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes","volume":"65","author":"Gnjidic","year":"2012","journal-title":"J. Clin. Epidemiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/pds.3772","article-title":"Polypharmacy and frailty: Prevalence, relationship, and impact on mortality in a French sample of 2350 old people","volume":"24","author":"Herr","year":"2015","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13044-014-0012-0","article-title":"The influence of thyroid dysfunction on bone metabolism","volume":"7","author":"Tuchendler","year":"2014","journal-title":"Thyroid Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00063-009-1135-2","article-title":"Osteoporosis\u2013current diagnostics and therapy","volume":"104","author":"Pfeilschifter","year":"2009","journal-title":"Med. Klin. Munich Ger."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kre\u010dak, I., Pivac, L., Lucijani\u0107, M., and Skelin, M. (2023). Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms. Biomedicines, 11.","DOI":"10.3390\/biomedicines11051301"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kupisz-Urba\u0144ska, M., P\u0142udowski, P., and Marcinowska-Suchowierska, E. (2021). Vitamin D Deficiency in Older Patients-Problems of Sarcopenia, Drug Interactions, Management in Deficiency. Nutrients, 13.","DOI":"10.3390\/nu13041247"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3961\/jpmph.2014.47.1.36","article-title":"Levothyroxine dose and fracture risk according to the osteoporosis status in elderly women","volume":"47","author":"Ko","year":"2014","journal-title":"J. Prev. Med. Public Health Yebang Uihakhoe Chi"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Moldovan, F., Moldovan, L., Moldovan, F., and Moldovan, L. (2025). The Impact of Total Hip Arthroplasty on the Incidence of Hip Fractures in Romania. J. Clin. Med., 14.","DOI":"10.3390\/jcm14134636"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.jfma.2023.05.001","article-title":"Epidemiology and clinical impact of osteoporosis in Taiwan: A 12-year trend of a nationwide population-based study","volume":"122","author":"Lee","year":"2023","journal-title":"J. Formos. Med. Assoc. Taiwan Yi Zhi"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Leng, P., Qiu, Y., Zhou, M., Zhu, Y., Yin, N., Zhou, M., Wu, W., and Liu, M. (2024). Hypothyroidism correlates with osteoporosis: Potential involvement of lipid mediators. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1453502"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s00391-012-0374-7","article-title":"Osteoporosis and polypharmacy","volume":"45","author":"Gosch","year":"2012","journal-title":"Z. Gerontol. Geriatr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0140-6736(92)92423-D","article-title":"Long-term thyroxine treatment and bone mineral density","volume":"340","author":"Franklyn","year":"1992","journal-title":"Lancet Lond. Engl."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00002512-200522010-00002","article-title":"Hypothyroidism in the elderly: Pathophysiology, diagnosis and treatment","volume":"22","author":"Laurberg","year":"2005","journal-title":"Drugs Aging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00198-024-07083-8","article-title":"Higher prevalence of thyroid-specific autoantibodies (TPOAb and TgAb) is related to a higher prevalence of fractures in females: Results from NHANES 2007\u20132010","volume":"35","author":"Wu","year":"2024","journal-title":"Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.amjmed.2010.02.028","article-title":"Drug-induced osteoporosis: Mechanisms and clinical implications","volume":"123","author":"Mazziotti","year":"2010","journal-title":"Am. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11926-008-0019-4","article-title":"Drug-induced osteoporosis: Beyond glucocorticoids","volume":"10","author":"Briot","year":"2008","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_28","first-page":"293","article-title":"Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study","volume":"64","author":"Appetecchia","year":"2005","journal-title":"Horm. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0755-4982(06)74854-0","article-title":"Non-corticosteroid drug-induced metabolic bone disease","volume":"35","author":"Briot","year":"2006","journal-title":"Presse Medicale Paris Fr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00198-009-0891-4","article-title":"Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates","volume":"20","author":"Vries","year":"2009","journal-title":"Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1503\/cmaj.071330","article-title":"Use of proton pump inhibitors and risk of osteoporosis-related fractures","volume":"179","author":"Targownik","year":"2008","journal-title":"CMAJ Can. Med. Assoc. J. J. Assoc. Medicale Can."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1359\/JBMR.051003","article-title":"Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: Results from a randomized controlled study with bumetanide","volume":"21","author":"Rejnmark","year":"2006","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11914-010-0028-x","article-title":"The role of FSH and TSH in bone loss and its clinical relevance","volume":"8","author":"Agrawal","year":"2010","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00198-015-3451-0","article-title":"Optimal age of commencing and discontinuing thiazide therapy to protect against fractures","volume":"27","author":"Kruse","year":"2016","journal-title":"Osteoporos. Int. J. Establ. Result Coop. Eur. Found. Osteoporos. Natl. Osteoporos. Found. USA"},{"key":"ref_35","first-page":"295","article-title":"Association between levothyroxine replacement therapy and osteoporosis in Riyadh, Saudi Arabia: A matched case-control study","volume":"77","author":"Alotaibe","year":"2022","journal-title":"Int. J. Pharm. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S2213-8587(18)30308-5","article-title":"Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): A prospective study","volume":"7","author":"Samelson","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical Practice. Postmenopausal Osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ecl.2012.04.006","article-title":"Pathophysiology of Osteoporosis. New Mechanistic Insights","volume":"41","author":"Armas","year":"2012","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bone.2016.06.009","article-title":"Frailty as a predictor of fractures among community-dwelling older people: A systematic review and meta-analysis","volume":"90","author":"Kojima","year":"2016","journal-title":"Bone"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1503\/cmaj.050051","article-title":"A global clinical measure of fitness and frailty in elderly people","volume":"173","author":"Rockwood","year":"2005","journal-title":"CMAJ"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"101498","DOI":"10.1016\/j.arr.2021.101498","article-title":"Prevalence of multidimensional frailty and pre-frailty in older people in different settings: A systematic review and meta-analysis","volume":"72","author":"Veronese","year":"2021","journal-title":"Ageing Res. Rev."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/3\/1197\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T14:04:57Z","timestamp":1770127497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/3\/1197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["jcm15031197"],"URL":"https:\/\/doi.org\/10.3390\/jcm15031197","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}